Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Feb;23(2):305–311. doi: 10.1128/iai.23.2.305-311.1979

Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread.

R R McKendall, T Klassen, J R Baringer
PMCID: PMC414165  PMID: 217828

Abstract

BALB/c mice passively immunized with antibody to herpes simplex virus type 1 and challenged in the footpad with 10(5.7) plaque-forming units of herpes simplex virus type 1 were shown to be protected from neurological disease and death compared with control mice treated with normal serum or antibody to Sindbis virus. One hundred percent of untreated mice had virus recoverable from dorsal root ganglia by 48 h after infection. Whereas amputation of the infected limb at 48 h had no effect, antibody administration (resulting in titers of 1:8 and 1:16) was found to prevent acute neurological disease if administered no later than 48 h after infection. Antibody also restricted the extent of latent infection in the lumbosacral ganglia. The data provide strong evidence that antibody is effective in preventing spread of virus both in the peripheral nervous system and in central nervous system (spinal cord) tissue.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cook M. L., Stevens J. G. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect Immun. 1973 Feb;7(2):272–288. doi: 10.1128/iai.7.2.272-288.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Douglas R. G., Jr, Couch R. B. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970 Feb;104(2):289–295. [PubMed] [Google Scholar]
  3. Fuccillo D. A., Catalano L. W., Jr, Moder F. L., Debus D. A., Sever J. L. Minicultures of mammalian cells in a new plastic plate. Appl Microbiol. 1969 Apr;17(4):619–622. doi: 10.1128/am.17.4.619-622.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fujibayashi T., Hooks J. J., Notkins A. L. Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes. J Immunol. 1975 Nov;115(5):1191–1193. [PubMed] [Google Scholar]
  5. Hooks J. J., Burns W., Hayashi K., Geis S., Notkins A. L. Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection. Infect Immun. 1976 Nov;14(5):1172–1178. doi: 10.1128/iai.14.5.1172-1178.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. JOHNSON R. T. THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING. J Exp Med. 1964 Feb 1;119:343–356. doi: 10.1084/jem.119.2.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kristensson K., Lycke E., Sjöstrand J. Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol. 1971;17(1):44–53. doi: 10.1007/BF00684740. [DOI] [PubMed] [Google Scholar]
  8. Kristensson K. Morphological studies of the neural spread of herpes simplex virus to the central nervous system. Acta Neuropathol. 1970;16(1):54–63. doi: 10.1007/BF00686964. [DOI] [PubMed] [Google Scholar]
  9. Luyet F., Samra D., Soneji A., Marks M. I. Passive immunization in experimental Herpesvirus hominis infection of newborn mice. Infect Immun. 1975 Dec;12(6):1258–1261. doi: 10.1128/iai.12.6.1258-1261.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McKendall R. R., Vogelzang N., Jackson G. G. Herpes virus latency in spinal ganglia of mice without illness. Proc Soc Exp Biol Med. 1974 Sep;146(4):1093–1096. doi: 10.3181/00379727-146-38251. [DOI] [PubMed] [Google Scholar]
  11. Oakes J. E. Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection. Infect Immun. 1975 Jul;12(1):166–172. doi: 10.1128/iai.12.1.166-172.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pauls F. P., Dowdle W. R. A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol. 1967 May;98(5):941–947. [PubMed] [Google Scholar]
  13. Price R. W., Walz M. A., Wohlenberg C., Notkins A. L. Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science. 1975 May 30;188(4191):938–940. doi: 10.1126/science.166432. [DOI] [PubMed] [Google Scholar]
  14. Rager-Zisman B., Allison A. C. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol. 1976 Jan;116(1):35–40. [PubMed] [Google Scholar]
  15. Renis H. E., Eidson E. E., Mathews J., Gray J. E. Pathogenesis of herpes simplex virus types 1 and 2 in mice after various routes of inoculation. Infect Immun. 1976 Aug;14(2):571–578. doi: 10.1128/iai.14.2.571-578.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Spruance S. L., Overall J. C., Jr, Kern E. R., Krueger G. G., Pliam V., Miller W. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med. 1977 Jul 14;297(2):69–75. doi: 10.1056/NEJM197707142970201. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES